Cite
Somekh I, Marquardt B, Liu Y, et al. Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma. J Clin Immunol. 2018;38(6):711doi: 10.1007/s10875-018-0541-8.
Somekh, I., Marquardt, B., Liu, Y., Rohlfs, M., Hollizeck, S., Karakukcu, M., Unal, E., Yilmaz, E., Patiroglu, T., Cansever, M., Frizinsky, S., Vishnvenskia-Dai, V., Rechavi, E., Stauber, T., Simon, A. J., Lev, A., Klein, C., Kotlarz, D., & Somech, R. (2018). Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma. Journal of clinical immunology, 38(6), 711. https://doi.org/10.1007/s10875-018-0541-8
Somekh, Ido, et al. "Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma." Journal of clinical immunology vol. 38,6 (2018): 711. doi: https://doi.org/10.1007/s10875-018-0541-8
Somekh I, Marquardt B, Liu Y, Rohlfs M, Hollizeck S, Karakukcu M, Unal E, Yilmaz E, Patiroglu T, Cansever M, Frizinsky S, Vishnvenskia-Dai V, Rechavi E, Stauber T, Simon AJ, Lev A, Klein C, Kotlarz D, Somech R. Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma. J Clin Immunol. 2018 Aug;38(6):711. doi: 10.1007/s10875-018-0541-8. PMID: 30099695.
Copy
Download .nbib